According to Globocan 2018, in both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths). In November all stakeholders mark the Lung Cancer Awareness Month and Lung Cancer Europe will continue to raise awareness about inequities regarding the access to lung […]
Category Archives: News
LuCE president, Stefania Vallone provided an insight analysis on “Being heard over the noise: The patient viewpoint” during #ESMO2018. She emphasized the role can patients and patient organizations play within the new therapies development and reimbursement. According to her, in lung cancer, time matters for patient, thus early diagnosis is crucial for a good prognosis. Anyhow, with patients who do/have […]
We invite all interested ESMO members to visit us @LuCE booth located in the society village at ESMO 2018 in Munich. Name: LuCE Hall: B1 Stand: PA 8 LuCE team will answer your questions and will provide materials and information about #lungcancer. Check out the map 1 and map 2 to easily find us.
New GLOBOCAN statistics placed lung cancer as the most frequent cancer and the leading cause of cancer death among males
According to tthe new statistics, in both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6 % of the total cases) and the leading cause of cancer death (18.4 % of the total cancer deaths), closely followed by female breast cancer (11.6 %), prostate cancer (7.1 %), and colorectal cancer (6.1 %) for incidence and colorectal cancer (9.2 […]